1. Intranuclear targeting of AML/CBFalpha regulatory factors to nuclear matrix-associated transcriptional domains. Zeng C, McNeil S, Pockwinse S, Nickerson J, Shopland L, Lawrence JB, Penman S, Hiebert S, Lian JB, van Wijnen AJ, Stein JL, Stein GS (1998) Proc Natl Acad Sci U S A 95(4): 1585-9
    › Primary publication · 9465059 (PubMed) · PMC19104 (PubMed Central)
  2. ETO, a target of t(8;21) in acute leukemia, interacts with the N-CoR and mSin3 corepressors. Lutterbach B, Westendorf JJ, Linggi B, Patten A, Moniwa M, Davie JR, Huynh KD, Bardwell VJ, Lavinsky RM, Rosenfeld MG, Glass C, Seto E, Hiebert SW (1998) Mol Cell Biol 18(12): 7176-84
    › Primary publication · 9819404 (PubMed) · PMC109299 (PubMed Central)
  3. E2F-1 and E2F-3 are functionally distinct in their ability to promote myeloid cell cycle progression and block granulocyte differentiation. Strom DK, Cleveland JL, Chellappan S, Nip J, Hiebert SW (1998) Cell Growth Differ 9(1): 59-69
    › Primary publication · 9438389 (PubMed)
  4. CBFa(AML/PEBP2)-related elements in the TGF-beta type I receptor promoter and expression with osteoblast differentiation. Ji C, Casinghino S, Chang DJ, Chen Y, Javed A, Ito Y, Hiebert SW, Lian JB, Stein GS, McCarthy TL, Centrella M (1998) J Cell Biochem 69(3): 353-63
    › Primary publication · 9581873 (PubMed)
  5. Transcriptional regulation during myelopoiesis. Lenny N, Westendorf JJ, Hiebert SW (1997) Mol Biol Rep 24(3): 157-68
    › Primary publication · 9291089 (PubMed)
  6. Subcellular partitioning of transcription factors during osteoblast differentiation: developmental association of the AML/CBF alpha/PEBP2 alpha-related transcription factor-NMP-2 with the nuclear matrix. Lindenmuth DM, van Wijnen AJ, Hiebert S, Stein JL, Lian JB, Stein GS (1997) J Cell Biochem 66(1): 123-32
    › Primary publication · 9215534 (PubMed)
  7. Runt homology domain proteins in osteoblast differentiation: AML3/CBFA1 is a major component of a bone-specific complex. Banerjee C, McCabe LR, Choi JY, Hiebert SW, Stein JL, Stein GS, Lian JB (1997) J Cell Biochem 66(1): 1-8
    › Primary publication · 9215522 (PubMed)
  8. Identification of a nuclear matrix targeting signal in the leukemia and bone-related AML/CBF-alpha transcription factors. Zeng C, van Wijnen AJ, Stein JL, Meyers S, Sun W, Shopland L, Lawrence JB, Penman S, Lian JB, Stein GS, Hiebert SW (1997) Proc Natl Acad Sci U S A 94(13): 6746-51
    › Primary publication · 9192636 (PubMed) · PMC21229 (PubMed Central)
  9. E2F-1 cooperates with topoisomerase II inhibition and DNA damage to selectively augment p53-independent apoptosis. Nip J, Strom DK, Fee BE, Zambetti G, Cleveland JL, Hiebert SW (1997) Mol Cell Biol 17(3): 1049-56
    › Primary publication · 9032231 (PubMed) · PMC231829 (PubMed Central)
  10. CBFA2, frequently rearranged in leukemia, is not responsible for a familial leukemia syndrome. Legare RD, Lu D, Gallagher M, Ho C, Tan X, Barker G, Shimizu K, Ohki M, Lenny N, Hiebert S, Gilliland DG (1997) Leukemia 11(12): 2111-9
    › Primary publication · 9447828 (PubMed)